Author:
McGoldrick Mic,Gastineau Thierry,Wilkinson Diane,Campa Cristiana,De Clercq Norbert,Mallia-Milanes Andrea,Germay Olivier,Krishnan Jyothsna,Van Ooij M,Thien Michael P,Mlynarczyk Peter J.,Saltus Edward,Wauters Florence,Juvin Philippe,Clenet Didier,Basso Ana,Dellepiane Nora,Pagliusi Sonia,Collaço de Moraes Stávale Monique,Sivaramakrishnan Venkatraman H,Desai Samir
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference30 articles.
1. Vaccine development for emerging infectious diseases;Excler;Nat Med,2021
2. Coronavirus (COVID-19) Vaccinations - Our World in Data, Project of the Global Change Data Lab; Website (sited 9-Jun-2021) https://ourworldindata.org/covid-vaccinations.
3. The COVAX Pillar; WHO Website (sited 15-Apr-2021) COVAX: The vaccines pillar of the access to COVID-19 tools (ACT) Accelerator (who.int).
4. EMA Guideline on process validation for finished products - information and data to be provided in regulatory submissions (EMA/CHMP/CVMP/QWP/BWP/70278/2012-Rev1, Corr.1), November 2016 https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-process-validation-finished-products-information-data-be-provided-regulatory-submissions_en.pdf.
5. ICH Quality Guidances; Website (sited 15-Apr-2021) https://www.ich.org/page/quality-guidelines.